Tag: COVID19

Scientific Review: Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients GIOSTAR | Potential Benefits of Stem Cells on COVID-19

Scientific Review: Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients

GIOSTAR leaders recently wrote on the potential benefits of stem cells in combating COVID-19. Published in Stem Cell Reviews and Reports, the review was written by Drs. Anand Srivastava, Prabhat Soni, Diana Esquivel, Rangnath Mishra, Rajasekar Seetharaman, and Anjum Mahmood

GIOSTAR Reports on a Positive Outcome of a COVID-19 Patient After Stem Cell Treatment GIOSTAR | COVID-19 | Positive Outcome

GIOSTAR Reports on a Positive Outcome of a COVID-19 Patient After Stem Cell Treatment

GIOSTAR recently treated a patient suffering from COVID-19 with stem cells. He experienced considerable improvement following this procedure. A placebo-controlled, double-blind study would be needed to better understand the measurable outcome of stem cell treatment for COVID-19.

Editorial: Mesenchymal stem cells may be a credible alternative therapy to fight with COVID-19 pandemic Drs. Anand Srivastava, Prabhat Soni - GIOSTAR

Editorial: Mesenchymal stem cells may be a credible alternative therapy to fight with COVID-19 pandemic

Drs. Anand Srivastava and Prabhat Soni write in a medical journal on the potential benefits of stem cells in fighting against COVID-19. GIOSTAR recently received FDA Approval Under Compassionate Use to treat COVID-19 patients under compassionate use.

GIOSTAR Speaks with Dr. Amy Killen on Their Efforts to Treat COVID-19 with Stem Cells GIOSTAR Talks to Dr. Amy Killen About COVID-19 and Stem Cells

GIOSTAR Speaks with Dr. Amy Killen on Their Efforts to Treat COVID-19 with Stem Cells

GIOSTAR Co-Founders Dr. Anand Srivastava and Deven Patel recently spoke with Dr. Amy Killen about the company's ongoing research efforts related to coronavirus (COVID-19). Dr. Anand explains in great detail the mechanisms underlying the disease, including cytokine storms and the potential immunomodulatory benefits of mesenchymal [...]
Vitro Biopharma Signs MOU with GIOSTAR for COVID-19 IND Using AlloRx Stem Cells GIOSTAR | Vitro Biopharma

Vitro Biopharma Signs MOU with GIOSTAR for COVID-19 IND Using AlloRx Stem Cells

GOLDEN, CO / ACCESSWIRE / June 2, 2020 / Vitro Diagnostics, Inc. (OTC PINK:VODG), dba Vitro entered into an exclusive Memorandum of Understanding (MOU) with Global Institute of Stem Cell Therapy and Research, Inc. ("GIOSTAR") a leading stem cell research institute based in San Diego, California. Under this agreement, [...]
Mesenchymal Stem Cell Therapy for COVID-19: Present & Future Laboratory Worker

Mesenchymal Stem Cell Therapy for COVID-19: Present & Future

Stem cell therapy has in recent years emerged as a potential alternative to invasive surgery, medication, and numerous other conventional approaches to patient care. Mesenchymal stem cells (MSCs) are particularly promising due to their relative abundance in adults, ease of harvesting, relatively minimal side effects, [...]
GIOSTAR Announces FDA Approval Under Compassionate Use to Treat COVID-19 Patients with Stem Cells Brunette Man Wearing Surgical Mask

GIOSTAR Announces FDA Approval Under Compassionate Use to Treat COVID-19 Patients with Stem Cells

Groundbreaking research provides a promising potential alternative to manage devastating pandemic Global Institute of Stem Cell Therapy and Research (GIOSTAR) is pleased to announce that they have received an approval for the emergency use of stem cell therapy to treat acute inflammation of the lungs in [...]